Norihiko Ito

Norihiko Ito

Auto-generated profile, based on publicly available information

Norihiko Ito

Veterinary Medical Center, Tottori University Koyama‐cho Minami Tottori Japan

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2012 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
PDF file
MTMasaki Takeuchi
Masaki Takeuchi
YAYuri Asukata
Yuri Asukata
TKTatsukata Kawagoe
Tatsukata Kawagoe
NINorihiko Ito
Norihiko Ito
TNTadayuki Nishide
Tadayuki Nishide
NMNobuhisa Mizuki
Nobuhisa Mizuki
Purpose: To compare infliximab monotherapy with infliximab and colchicine combination therapy in Behçet’s disease. Methods: Clinical records of 14 Behçet’s disease patients who were administered infliximab with or without colchicine were retrospectively reviewed. Patients who were given other immunosuppresants after initiation of infliximab therapy were excluded. The frequency of ocular attacks and best-corrected visual acuity were investigated. Results: Seven patients received monotherapy and 7 received combination therapy. The mean frequency of ocular attacks significantly decreased from 2.14 to 0.22 per 6 months in monotherapy group and from 2.57 to 0.18 per 6 months in combination therapy group. No significant difference was observed between both groups in the frequency of ocular attacks and in changes in best-corrected visual acuity during 0 to 24 months. Conclusions: Infliximab is as efficacious as infliximab and colchicines together in Behçet’s disease treatment. This study suggests that colchicine administration is not necessary in Behçet’s disease patients receiving infliximab.

1 June 2014 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
KTKazuki Tajima
Kazuki Tajima
TMTaku Miyake
Taku Miyake
NKNaohito Koike
Naohito Koike
THTakaaki Hattori
Takaaki Hattori
SKShigeto Kumakura
Shigeto Kumakura
HGHiroshi Goto
Hiroshi Goto

14 January 2016 in Veterinary and Comparative Oncology
Verified
Journal Article
Closed access
PDF file
TOTomohiro Osaki
Tomohiro Osaki
IYI. Yokoe
I. Yokoe
SOS. Ogura
S. Ogura
KTK. Takahashi
K. Takahashi
KMK. Murakami
K. Murakami
YOYasuhiro Okamoto
Yasuhiro Okamoto

1 November 2001 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
KKKazuaki Kadonosono
Kazuaki Kadonosono
STSatoshi Takeuchi
Satoshi Takeuchi
SIShinko Iwata
Shinko Iwata
EUEiichi Uchio
Eiichi Uchio
NINorihiko Itoh
Norihiko Itoh
JAJunsuke Akura
Junsuke Akura

1 November 2019 in Journal of Dairy Science
Verified
Journal Article
Closed access
TTTakeshi Tsuka
Takeshi Tsuka
RNR. Nishimura
R. Nishimura
MHM. Hishinuma
M. Hishinuma
YMY. Murahata
Y. Murahata
MYM. Yamashita
M. Yamashita
TIT. Imagawa
T. Imagawa
The goal of the present study was to determine the effect of sole horn thickness (SHT) and sole horn hardness (SHD) on ultrasonographic visualization of sole structures in the inner and outer claws of 150 Holstein-Friesian cows, and to evaluate different ultrasound frequencies for this purpose. Ultrasonographic views of the sole structure were considered complete when 3 echogenic lines, representing the ventral surface of the sole horn, the borders of the sole horn and soft-tissue layer, and the ventral surface of the distal phalanx, were seen. The proportion of complete ultrasonographic views of the sole structures, designated as the ultrasonographic visualization proportion (UVP), and the measurement errors of SHT were evaluated by comparing images from computed tomography (CT) and ultrasonography. The latter images were generated using 3 different probes, frequencies of 6.5 and 5.0 MHz, and 2 different ultrasound machines (#1 and #2) to assess the apex, middle, and heel regions of the claws. The UVP were 60.8 to 77.9% for the 6.5-MHz probe in ultrasound machine #1 (probe A), which were lower than those (>90%) for both the 5.0-MHz probe in ultrasound machine #1 (probe B) and the 5.0-MHz probe in ultrasound machine #2 (probe C). The UVP was significantly lower in claws with an SHD ≥50 units than in claws with an SHD <40 or 40 to <50 units (UVP: 77.1% compared with 93.7 and 91.4%, respectively) when measured with probe B. In claws with an SHT <10 mm, the UVP was significantly lower when SHD was ≥50 units compared with 50 units; the values were 69.0% versus 91.3 and 85.9%, respectively, for probe A, and 89.7% versus 100 and 100%, respectively, for probe B. When SHT were measured by either probes A or B in ultrasound machine #1, the proportions of claws in which ultrasonographic values were within a ±1 mm range compared with the values obtained by CT were 84.9 to 91.3% for CT-determined SHT <5 mm, 66.7 to 71.9% for CT-determined SHT 5 to <7 mm, 28.9 to 51.2% for CT-determined SHT 7 to <10 mm, and 6.2 to 19.7% for CT-determined SHT ≥10 mm. The data indicated that increased SHT was associated with a decrease in ultrasonographic measurement accuracy. In claws with an SHT <5 mm, the high proportion of ultrasonographic values that were accurate within a ±1 mm range suggests that this imaging modality would be useful in cows with thin soles.

1 January 2005 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
NMNobuhisa Mizuki
Nobuhisa Mizuki
YWYoichiro Watanabe
Yoichiro Watanabe
MMMariko Miyamoto
Mariko Miyamoto
YIYasuhito Iijima
Yasuhito Iijima
NTNaoaki Takiyama
Naoaki Takiyama
DIDaizo Ito
Daizo Ito
We intravenously administered flomoxef sodium (FMOX) 120 minutes before cataract surgery, topically administered levofloxacin (LVFX) into the eyes four times at 30-minute intervals before surgery, and measured the aqueous humor concentrations of these agents to investigate their penetration into the aqueous humor and their efficacy in the prevention of postoperative endophthalmitis. Sixty-eight patients who underwent cataract surgery at the Department of Ophthalmology, Yokohama City University School of Medicine, or its affiliate, Kanazawa Hospital, Yokohama, were enrolled in this study. They received one or both of the following: 1.0 g FMOX via a 20-minute intravenous drip and LVFX ophthalmic solution applied four times at 30-minute intervals, both beginning two hours before the operation. Aqueous humor was aspirated from the anterior chamber and assayed for FMOX and LVFX concentrations using high-performance liquid chromatography (HPLC). The mean intraoperative FMOX and LVFX concentrations in the patients' aqueous humor were 1.21 +/- 0.63 microg/ml and 0.69 +/- 0.47 microg/ml, respectively. These concentrations sufficiently exceeded the MIC90 values against Staphylococcus epidermidis, S. aureus, and Propionibacterium acnes. The FMOX and LVFX concentrations in the aqueous humor sampling were adequate to kill bacteria in vitro. These drugs may have efficacy in the prevention of postoperative endophthalmitis in patients undergoing cataract surgery.